Revvity, Inc. (RVTY) Stock Analysis
Healthcare · Diagnostics & Research
Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $85.74 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Supplier: limited or single sources of supply; Earnings in 5 days (event risk).
Revvity provides health science tools across Life Sciences and Diagnostics segments, serving pharmaceutical, biotech, academic, and government customers in 160+ countries with approximately 11,000 employees. Revenue is generated through instruments, reagents, software, and... Read more
Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $85.74 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Supplier: limited or single sources of supply; Earnings in 5 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 4.9/10, moderate confidence.
Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSupplierlimited or single sources of supply10-K Item 1A: 'certain critical raw materials, key components and other goods ... are available from limited or single sources of supply'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 1.3/10 is below the 5.0 floor at $85.74 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Supplier: limited or single sources of supply; Earnings in 5 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $79.83. Score 4.9/10, moderate confidence.
Take-profit target: $99.12 (+15.5% upside). Prior stop was $79.83. Stop-loss: $79.83.
Concentration risk — Supplier: limited or single sources of supply; Earnings in 5 days (event risk); Weak overall score: 4.9/10.
Revvity, Inc. trades at a P/E of 39.9 (forward 13.7). TrendMatrix value score: 7.1/10. Verdict: Sell.
26 analysts cover RVTY with a consensus score of 3.8/5. Average price target: $114.
What does Revvity, Inc. do?Revvity provides health science tools across Life Sciences and Diagnostics segments, serving pharmaceutical, biotech,...
Revvity provides health science tools across Life Sciences and Diagnostics segments, serving pharmaceutical, biotech, academic, and government customers in 160+ countries with approximately 11,000 employees. Revenue is generated through instruments, reagents, software, and services across drug discovery, diagnostics, and screening workflows.